The gut-placenta axis in preeclampsia: unraveling the regulatory network and clinical prospects in pathogenesis
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1697739 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Ningxia Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Center, Gansu Province Maternity and Child-care Hospital, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Placenta, Gastrointestinal Microbiome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Preeclampsia (PE) is a pregnancy-specific hypertensive disorder that develops after 20 weeks of gestation, characterized by hypertension and proteinuria or multi-organ dysfunction. representing a leading cause of maternal and perinatal morbidity and mortality worldwide. The pathogenesis of PE is complex and remains incompletely understood, involving shallow placentation, endothelial dysfunction, immune imbalance, and systemic inflammation;however, the initiating triggers remain are unclear. Recent research has highlighted the gut microbiota-often termed the “second genome” -for its critical role in metabolic and immune homeostasis. Dynamic alterations in maternal gut microbial composition during pregnancy are closely associated with maternal and fetal health. Concurrently, placental exosomes, have emerged as key mediators of intercellular communication. These membrane-bound extracellular vesicles, released by placental cells, are capable of delivering microRNAs, proteins, and lipids into the maternal circulation to exert systemic effects. The emerging concept of a “gut microbiota-placental -exosome axis” suggests a pivotal role in PE progression. This review explores the bidirectional interactions between gut microbiota and placental exosomes, their regulatory impact on maternal-fetal immune crosstalk and endothelial function, and their contribution to PE pathophysiology. We also identify current research gaps and propose future directions, offering a theoretical basis for early biomarkers and targeted therapies for PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory Center, Gansu Province Maternity and Child-care Hospital, Lanzhou, Gansu, China.
- Department of Ultrasound Medical Center, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, Gansu, China.
Zitieren
APA
Ma, N., Cao, H., Ma, Y., Yin, J., Yan, J., Pei, J., & Zhang, C. (2025). The gut-placenta axis in preeclampsia: unraveling the regulatory network and clinical prospects in pathogenesis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1697739
Vancouver
Ma N, Cao H, Ma Y, Yin J, Yan J, Pei J, et al. The gut-placenta axis in preeclampsia: unraveling the regulatory network and clinical prospects in pathogenesis. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1697739
BibTeX
@article{Ma2025,
author = {Ma, Ningxia and Cao, Haibo and Ma, Yao and Yin, Jiaojiao and Yan, Jing and Pei, Jianying and Zhang, Chong},
title = {The gut-placenta axis in preeclampsia: unraveling the regulatory network and clinical prospects in pathogenesis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1697739}
}
EUVIMED